Managers / Q3 2023
Canaan Partners X LLC
CIK 0001673228 · 2765 SAND HILL ROAD, MENLO PARK, CA, 94025 · 6508548092
Summary
Canaan Partners X LLC reported $75M in U.S.-listed holdings across 2 positions for Q3 2023.
The portfolio is heavily concentrated: IDYA alone accounts for 96.1% of reported value.
Compared with Q2 2023, the fund opened 0 new positions and exited 1.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 96.1% · $72M
- Other · 3.9% · $3M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| Berkshire Grey Inc | SOLD OUT | −14.15M | 0 | −$20M | $0 |
| IDYAIDEAYA Biosciences Inc | HELD | +0 | 2.66M | +$9M | $72M |
| MONEYLION INC | HELD | +0 | 136.0K | +$1M | $3M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2023
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | IDYAIDEAYA Biosciences Inchistory → | COM | 96.06% | $72M | 2.66M |
| 2 | MONEYLION INC | CL A | 3.94% | $3M | 136.0K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2023 | $75M | 2 | Oct 11, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $84M | 3 | Jul 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $56M | 2 | Apr 6, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $57M | 2 | Feb 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $64M | 3 | Oct 31, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $58M | 4 | Aug 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $98M | 4 | Apr 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $257M | 4 | Feb 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $351M | 5 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $67M | 3 | Jul 22, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $73M | 3 | May 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $48M | 3 | Feb 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $50M | 3 | Oct 26, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $83M | 3 | Aug 10, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $91M | 3 | May 11, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $155M | 3 | Jan 27, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.